TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $295,000 | -7.8% | 22,771 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $320,000 | -1.8% | 22,771 | 0.0% | 0.02% | +14.3% |
| Q1 2022 | $326,000 | +5.2% | 22,771 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $310,000 | -23.6% | 22,771 | -8.0% | 0.01% | -33.3% |
| Q3 2021 | $406,000 | -13.8% | 24,759 | -11.6% | 0.02% | -10.0% |
| Q2 2021 | $471,000 | -7.8% | 28,010 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $511,000 | +0.2% | 28,010 | 0.0% | 0.02% | -4.0% |
| Q4 2020 | $510,000 | +2.0% | 28,010 | 0.0% | 0.02% | -10.7% |
| Q3 2020 | $500,000 | -0.4% | 28,010 | 0.0% | 0.03% | -9.7% |
| Q2 2020 | $502,000 | +18.1% | 28,010 | 0.0% | 0.03% | 0.0% |
| Q1 2020 | $425,000 | -23.1% | 28,010 | 0.0% | 0.03% | -3.1% |
| Q4 2019 | $553,000 | +14.7% | 28,010 | 0.0% | 0.03% | +6.7% |
| Q3 2019 | $482,000 | -2.8% | 28,010 | 0.0% | 0.03% | -14.3% |
| Q2 2019 | $496,000 | -13.1% | 28,010 | 0.0% | 0.04% | -12.5% |
| Q1 2019 | $571,000 | – | 28,010 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |